Related references
Note: Only part of the references are listed.Global distribution of CYP2C19 risk phenotypes affecting safety and effectiveness of medications
Mohitosh Biswas
PHARMACOGENOMICS JOURNAL (2021)
Genetic insight into cytochrome P450 in Chinese from the Chinese Millionome Database
Guangzhao Qi et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2020)
Genetic and epigenetic polymorphisms of eNOS and CYP2D6 in mainland Chinese Tibetan, Mongolian, Uygur, and Han populations
Guangzhao Qi et al.
PHARMACOGENOMICS JOURNAL (2020)
Added Value of Clinical Sequencing: WGS-Based Profiling of Pharmacogenes
Sylvan M. Caspar et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The mutational constraint spectrum quantified from variation in 141,456 humans
Konrad J. Karczewski et al.
NATURE (2020)
Whole genome sequencing identifies high-impact variants in well-known pharmacogenomic genes
Jihoon Choi et al.
PHARMACOGENOMICS JOURNAL (2019)
Association of SLC15A1 polymorphisms with susceptibility to dyslipidaemia in a Chinese Han population
Shu Liu et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2019)
DrugBank 5.0: a major update to the DrugBank database for 2018
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2018)
Impact of VKORC1, CYP4F2 and NQO1 gene variants on warfarin dose requirement in Han Chinese patients with catheter ablation for atrial fibrillation
Jiao Li et al.
BMC CARDIOVASCULAR DISORDERS (2018)
Clinical pharmacogenomics testing in the era of next generation sequencing: challenges and opportunities for precision medicine
Yuan Ji et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2018)
Pharmacogenomic survey of Qatari populations using whole-genome and exome sequences
Ambily Sivadas et al.
PHARMACOGENOMICS JOURNAL (2018)
Integrating rare genetic variants into pharmacogenetic drug response predictions
Magnus Ingelman-Sundberg et al.
HUMAN GENOMICS (2018)
Genetic epidemiology of pharmacogenetic variants in South East Asian Malays using whole-genome sequences
A. Sivadas et al.
PHARMACOGENOMICS JOURNAL (2017)
Systematic screening for CYP3A4 genetic polymorphisms in a Han Chinese population
Guo-Xin Hu et al.
PHARMACOGENOMICS (2017)
Analysis of population-specific pharmacogenomic variants using next-generation sequencing data
Eunyong Ahn et al.
SCIENTIFIC REPORTS (2017)
Opportunities and challenges of whole-genome and -exome sequencing
Britt-Sabina Petersen et al.
BMC GENETICS (2017)
Complex heatmaps reveal patterns and correlations in multidimensional genomic data
Zuguang Gu et al.
BIOINFORMATICS (2016)
The role of pharmacogenetics in capecitabine efficacy and toxicity
S. W. Lam et al.
CANCER TREATMENT REVIEWS (2016)
dbNSFP v3.0: A One-Stop Database of Functional Predictions and Annotations for Human Nonsynonymous and Splice-Site SNVs
Xiaoming Liu et al.
HUMAN MUTATION (2016)
Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine
Shabbir Ahmed et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2016)
Vcfanno: fast, flexible annotation of genetic variants
Brent S. Pedersen et al.
GENOME BIOLOGY (2016)
A global reference for human genetic variation
David M. Altshuler et al.
NATURE (2015)
Whole genome sequencing in pharmacogenomics
Theodora Katsila et al.
FRONTIERS IN PHARMACOLOGY (2015)
Second-generation PLINK: rising to the challenge of larger and richer datasets
Christopher C. Chang et al.
GIGASCIENCE (2015)
Genetic Variations of Drug Transporters Can Influence on Drug Response in Patients Treated with Docetaxel Chemotherapy
Jung Ran Choi et al.
CANCER RESEARCH AND TREATMENT (2015)
Trimmomatic: a flexible trimmer for Illumina sequence data
Anthony M. Bolger et al.
BIOINFORMATICS (2014)
MutationTaster2: mutation prediction for the deep-sequencing age
Jana Marie Schwarz et al.
NATURE METHODS (2014)
Pharmacogenomics, ancestry and clinical decision making for global populations
E. Ramos et al.
PHARMACOGENOMICS JOURNAL (2014)
CYP2C9 polymorphism analysis in Han Chinese populations: building the largest allele frequency database
D-P Dai et al.
PHARMACOGENOMICS JOURNAL (2014)
Challenges in the Pharmacogenomic Annotation of Whole Genomes
R. B. Altman et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Genetic variations of human CYP2D6 in the Chinese Han population
Jian-Chang Qian et al.
PHARMACOGENOMICS (2013)
Pharmacogenomics Knowledge for Personalized Medicine
M. Whirl-Carrillo et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3
Pablo Cingolani et al.
FLY (2012)
Genetic polymorphisms and novel allelic variants of CYP2C19 in the Chinese Han population
Li-Ming Hu et al.
PHARMACOGENOMICS (2012)
The variant call format and VCFtools
Petr Danecek et al.
BIOINFORMATICS (2011)
A framework for variation discovery and genotyping using next-generation DNA sequencing data
Mark A. DePristo et al.
NATURE GENETICS (2011)
A method and server for predicting damaging missense mutations
Ivan A. Adzhubei et al.
NATURE METHODS (2010)
A microarray-based system for the simultaneous analysis of single nucleotide polymorphisms in human genes involved in the metabolism of anti-malarial drugs
Eva Maria Hodel et al.
MALARIA JOURNAL (2009)
The role of ethnicity in variability in response to drugs: Focus on clinical pharmacology studies
S. U. Yasuda et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
VKORC1 polymorphisms, haplotypes and haplotype groups on warfarin dose among African-Americans and European-Americans
Nita A. Limdi et al.
PHARMACOGENOMICS (2008)
Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose
MJ Rieder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
SIFT: predicting amino acid changes that affect protein function
PC Ng et al.
NUCLEIC ACIDS RESEARCH (2003)
dbSNP: the NCBI database of genetic variation
ST Sherry et al.
NUCLEIC ACIDS RESEARCH (2001)
Share Paper
